2026 NPPES data Podiatrist NPI 1093782427 DPM
Verify on CMS →

MARK WITT, DPM

Podiatrist in LONGVIEW, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
666
Medicare Part D claims · 352 beneficiaries · Podiatrist avg: 304
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$18.09
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK WITT, DPM filed 666 Medicare Part D claims in 2023 as a Podiatrist in LONGVIEW, Texas, prescribing 97% generic.

666
Part D claims, 2023
97%
generic prescribing
$18.09
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK WITT, DPM's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

666 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MARK WITT, DPM?

Quality data not reported

NPI registry status

Active

Issued 03/03/2006

NPI 1093782427

Primary specialty

Podiatrist

Mid-sized

10,498 US NPIs in this specialty

Medicare Part D claims

666 119% vs specialty avg

2023 prescription claims

Specialty avg: 304

Specialty distribution in Texas

How Podiatrist compares to other specialties among Texas providers

Texas providers

Podiatrist share within Texas

1. Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Podiatrist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Podiatrist ABMS/AOA estimate

Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK WITT, DPM appears in the CMS NPPES registry as a Podiatrist provider holding DPM credentials at 709 HOLLYBROOK DR, LONGVIEW, TX, 75605, with a listed phone of (903) 753-1778. NPI 1093782427 was issued on 03/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WITT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 666 prescription claims written by this provider, covering 352 Medicare beneficiaries and totaling roughly $27K in drug spend, split 3% brand-name and 97% generic by claim count, with an opioid prescribing rate of 10.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

709 HOLLYBROOK DR
LONGVIEW, TX 75605

Provider Details

NPI 1093782427
Specialty Podiatrist
Credentials DPM
Gender Male
NPI Issued 03/03/2006

Hospital and facility affiliations

Facilities where MARK WITT, DPM bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ASSOCIATED CLINICIANS OF EAST TEXAS
LONGVIEW, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK WITT, DPM. Source: openpaymentsdata.cms.gov.

Total received

$18

Largest payer

Pylant Medical

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MARK WITT, DPM. To verify MARK WITT, DPM's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK WITT, DPM — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 666 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

666
Total Claims
$27K
Total Drug Cost
352
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
731
Total Day Supply
14,059
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$17K
Generic Drug Cost
$10K
Opioid Claims
69 (10.4% rate)
Antibiotic Claims
163

Patient Demographics

Average Patient Age
71.6 years
Avg HCC Risk Score
1.49
Gender Split
59% female / 41% male
Age Distribution
<65: 45, 65-74: 175, 75-84: 113, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK WITT, DPM prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Meloxicam
140
Methylprednisolone
102
Cephalexin
77
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
59
Diclofenac Sodium
55
Pregabalin
46
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
43
Ciclopirox
31
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
21
Celecoxib
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Podiatrist Overview

How MARK WITT, DPM fits within the Podiatrist landscape nationally.

10,498
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider

MARK WITT, DPM's 666 claims are above the specialty average of 304.

Nearby Podiatrist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as WITT.

Compare Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK WITT, DPM's specialty?
MARK WITT, DPM specializes in Podiatrist and practices in LONGVIEW, Texas. Credentials: DPM.
How much does MARK WITT, DPM prescribe under Medicare Part D?
In 2023, MARK WITT, DPM wrote 666 Medicare Part D claims totaling $27K in drug costs for 352 beneficiaries.
Where is MARK WITT, DPM located?
MARK WITT, DPM is located at 709 HOLLYBROOK DR, LONGVIEW, TX, 75605. Phone: (903) 753-1778.
What is MARK WITT, DPM's NPI number?
MARK WITT, DPM's National Provider Identifier (NPI) is 1093782427, issued on 03/03/2006.
Does MARK WITT, DPM prescribe more brand-name or generic drugs?
MARK WITT, DPM's prescribing is 3% brand-name and 97% generic drugs by claim count, with $17K in brand drug costs.
Does MARK WITT, DPM prescribe opioids?
Yes, MARK WITT, DPM had 69 opioid claims in 2023 with an opioid prescribing rate of 10.4%.
How many Podiatrist providers are there in the US?
There are 10,498 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does MARK WITT, DPM prescribe most often?
Based on 2023 Medicare Part D data, MARK WITT, DPM's most frequently prescribed drugs include Meloxicam, Methylprednisolone, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK WITT, DPM accept Medicare?
MARK WITT, DPM appears in CMS Medicare data with 666 Part D claims and 352 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK WITT, DPM's credentials?
MARK WITT, DPM's NPI is 1093782427 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology